Saved source observation · CN4164112-A1

Supply of Essential Vaccines to the National Immunisation Program

A later observation replaced this one. The explorer’s totals use $431,005,979.56 from the latest observation, published 1 July 2026.

$431,209,246.66

Full reported contract value · AUD including applicable GST · 2025-07-01 to 2026-06-30

Reporting agency
Department of Health, Disability and Ageing
Reported supplier
GlaxoSmithKline Australia Pty Ltd
Reported ABN
47 100 162 481. Exemption as supplied: No.
Category
Drugs and Pharmaceutical Products
Procurement method
Open tender
Original publication
2025-06-27 15:33:00 (ACT local time as supplied)
Amendment publication
2026-05-13 15:03:00 (ACT local time as supplied)
Amendment reason
Variation to contract value
Agency reference
4500160500
Approach to market / standing offer
RFT 003/1617 / SON3518274
Consultancy
No
Confidentiality as reported
Contract: Yes; outputs: No
Source observation
CN4164112-A1 · Official weekly workbook ending 2026-05-16 · sheet “Contract Notice Export”, row 708.

The original register may now show later corrections. The card and this observation keep the saved source date.